海外の治験の状況「1」での検索結果
98件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not Available
- A Two-Part Study of ZX008 in Children and Adults with Lennox-Gastaut Syndrome (LGS); Part 1: A Randomized, Double-blind, Placebo-controlled Trial of Two Fixed Doses of ZX008 (Fenfluramine Hydrochloride) Oral Solution as Adjunctive Therapy for Seizures in Children and Adults with LGS, Followed by Part 2: An Open-label Extension to Assess Long-Term Safety of ZX008 in Children and Adults with LGS
- Lennox-Gastaut Syndrome in Children and Adults MedDRA version: 20.1 Level: PT Classification code 10048816 Term: Lennox-Gastaut syndrome System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Mexico, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, United Kingdom, United States
- 2018-04-11
Not Available
- A Non-Interventional Study to Monitor the Survival Status of Patients that Discontinued from ISIS 420915-CS2 or ISIS 420915-CS3
- Familial Amyloid Polyneuropathy br>MedDRA version: 20.0 Level: LLT Classification code 10057949 Term: Familial amyloid polyneuropathy System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Argentina, Brazil, France, Germany, Italy, New Zealand, Portugal, Spain, United Kingdom, United States
- 2018-02-27
Not Available
- This study will test an experimental drug named GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) for the possible treatment of human immunodeficiency virus (HIV) infection in children and adolescents. The purpose of this study is to determine the concentration of GS-9883 in your child’s body, and confirm the safety, tolerability and dose of GS-9883/F/TAF in HIV-1 infected, virologically suppressed adolescents (12 to < 18 years of age) and children (6 to < 12 years of age).
- Human Immunodeficiency Virus (HIV-1) Infection MedDRA version: 19.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02];Human Immunodeficiency Virus (HIV-1) Infection MedDRA version: 19.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02];Human Immunodeficiency Virus (HIV-1) Infection MedDRA version: 19.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- South Africa, Thailand, Uganda, United States
- 2016-06-29
Not Available
- N/A
- MedDRA version: 18.0 Level: LLT Classification code 10070916 Term: Familial hemophagocytic lymphohistiocytosis System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- France
- 2015-05-18
Not Available
- A study to compare a pediatric tablet or suspension of elvitegravir verses the adult 150 mg tablet in healthy adult volunteers
- Human Immunodeficiency Virus (HIV-1) Infection MedDRA version: 17.1 Level: LLT Classification code 10020192 Term: HIV-1 System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- United States
- 2015-02-18
Not Available
- A study to compare two pediatric formulations to the adult formulation of cobicistat 150 mg tablet in healthy adult volunteers
- Human Immunodeficiency Virus (HIV-1) Infections MedDRA version: 17.1 Level: LLT Classification code 10068341 Term: HIV-1 infection System Organ Class: 100000004862 ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- United States
- 2015-02-04
Not Available
- Phase II Study of Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
- Philadelphia Chromosome Positive Acute Lymphocytic Leukemia (Ph+ALL);Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Japan
- 2017-08-15
Not Available
- An Open-label, Multicenter, Phase 2 Study Evaluating the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Subjects =1 and =30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma MedDRA version: 20.0 Level: LLT Classification code 10000845 Term: Acute lymphoblastic leukemia System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10066109 Term: Precursor B-lymphoblastic leukemia acute System Organ Class: 100000004864 MedDRA version: 20.0 Level: LLT Classification code 10066110 Term: T-cell lymphoblastic leukemia acute System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Spain, Sweden, United Kingdom, United States
- 2018-02-27
Not Available
- Adult Lamivudine and Tenofovir Biocomparison Study for Pediatric Fixed Dose Combination Formulation
- HIV-1 infection MedDRA version: 19.0 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Canada
- 2016-11-21
Not Available
- A Study of the Comparative Bioavailability of Two Second-Generation Investigational Pediatric Oral Granule Formulations of MK-1439 Compared to the Adult Formulation
- HIV-1 Infection MedDRA version: 19.0 Level: PT Classification code 10020161 Term: HIV infection System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Virus Diseases [C02]
- Canada
- 2016-11-16